PRESS RELEASE published on 05/09/2023 at 07:30, 2 years 6 months ago APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills
PRESS RELEASE published on 05/08/2023 at 07:30, 2 years 6 months ago APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development partnership with Zentiva Group for another Single Pill with EU-wide intellectual property rights
PRESS RELEASE published on 05/03/2023 at 13:00, 2 years 7 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Bioleaching Potential for the W4 Nickel Sulphides
PRESS RELEASE published on 05/02/2023 at 21:50, 2 years 7 months ago EQS-Adhoc: APONTIS PHARMA AG adjusts forecast for fiscal year 2023
PRESS RELEASE published on 04/27/2023 at 07:30, 2 years 7 months ago APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary prophylaxis of cardiovascular events - market launch already planned for early 2024
PRESS RELEASE published on 04/20/2023 at 13:00, 2 years 7 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Carbon Capture and Storage ("CCS") Potential of the CarLang Area
PRESS RELEASE published on 04/12/2023 at 13:00, 2 years 7 months ago EV Nickel Announces Filing of NI 43-101 Technical Report for Previously Announced CarLang Project Maiden Resource
PRESS RELEASE published on 04/12/2023 at 07:30, 2 years 7 months ago APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential
PRESS RELEASE published on 03/28/2023 at 13:00, 2 years 8 months ago EV Nickel Continues to Expand the High-Grade W4 Zone with Impressive Nickel Drill Hole Intercepts Including 13.1m Grading 1.47% Ni and 2.1m Grading 3.01% Ni
PRESS RELEASE published on 03/09/2023 at 07:30, 2 years 8 months ago APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations
Published on 12/05/2025 at 02:35, 9 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:30, 1 hour 12 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 27 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 2 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 2 hours 12 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 08:45, 2 hours 57 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 58 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
